Breathing disorders, ranging from common conditions like asthma to more severe illnesses such as chronic obstructive pulmonary disease (COPD), pose significant challenges to millions of people worldwide. As the prevalence of respiratory ailments continues to rise, there is a growing need for innovative and effective treatment options.
Philips Healthcare Announced the expansion of their BioTelemetry Platform in January 2024, enabling remote monitoring of a wider range of vital signs and physiological parameters for improved patient care, including breathing difficulties.
ResMed Launched the AirTouch™ F20 Full Face Mask in October 2023, featuring a soft and flexible design for more comfortable sleep apnea therapy.
Masimo Corporation Received FDA approval for their Radius-7 Pulse Oximeter in December 2023, offering continuous monitoring of blood oxygen saturation and pulse rate, helpful for managing breathing disorders.
Propeller Health Partnered with a major health insurance company in February 2024 to provide their Propeller Breathe digital therapeutic app for asthma management to a wider user base.
Air Liquide Announced the development of a next-generation high-flow nasal oxygen therapy (HFNO) device in November 2023, aiming to offer improved comfort and treatment efficacy for respiratory insufficiency.
Breathing Disorders & Treatment Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)